A study published in The Lancet found that Tylenol use among pregnant women decreased after former US President Donald Trump linked the pain relief medicine to autism. The analysis of US emergency room prescribing patterns showed a 10% drop in Tylenol orders for pregnant women.
Trump’s claim was met with scepticism from health officials and medical experts, who cited a lack of evidence supporting a link between Tylenol and autism. Kenvue, the manufacturer of Tylenol, stated that acetaminophen is the safest option for pain and fever relief during pregnancy.
Interestingly, the study also found a 71% increase in prescriptions for leucovorin, a form of folinic acid touted by Trump as a treatment for autism. However, medical experts warned that there’s limited evidence supporting its use for this purpose.
The study’s findings highlight the impact of public statements on healthcare decisions and the need for evidence-based information.
